Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review

Outcomes in Patients With von Willebrand Disease Receiving Recombinant von Willebrand Factor on Demand and in Surgical Settings: Chart Review

This European observational chart review assessed the efficacy/safety of recombinant von Willebrand factor (rVWF) for on-demand treatment of spontaneous/traumatic bleeds and prevention and/or treatment of surgery-related bleeding in adults with von Willebrand disease (VWD). Patients (n = 91) were en...

Full description

Bibliographic Details
Main Authors:	Shawn X. Sun PhD, Shannely Lowndes MSc, CAS, Rosa Willock MSc, Cheryl Jones PhD, Sarah Brighton BSc
Format:	Article
Language:	English
Published:	SAGE Publishing 2023-06-01
Series:	Clinical and Applied Thrombosis/Hemostasis
Online Access:	https://doi.org/10.1177/10760296231177294

Similar Items

Endothelial Function in Patients With Von Willebrand Disease
by: Stephanie Noone MD, et al.
Published: (2021-01-01)

The Cost of Von Willebrand Disease in Europe: The CVESS Study
by: George Morgan MSc, et al.
Published: (2022-08-01)

Disease Burden in Patients with von Willebrand Disease Potentially Eligible for Prophylaxis: Post Hoc Analysis of a European Cross-Sectional Study
by: Ping Du MD, PhD, et al.
Published: (2022-12-01)

The Importance and Complications of Sequencing of Von Willebrand Gene in Von Willebrand Disease
by: Zolkova J, et al.
Published: (2019-04-01)

Doença de von Willebrand e anestesia Enfermedad de von Willebrand y anestesia Von Willebrand's disease and anesthesia
by: Fabiano Timbó Barbosa, et al.
Published: (2007-06-01)

In Vitro Assessment of von Willebrand Factor in Cryoprecipitate, Antihemophilic Factor/VWF Complex (Human), and Recombinant von Willebrand Factor
by: Meaghan E. Colling MD, et al.
Published: (2019-09-01)

VON WILLEBRAND DISEASE
by: Valeriu Popescu, et al.
Published: (2009-11-01)

Diagnostic Value of Measuring Platelet Von Willebrand Factor in Von Willebrand Disease.
by: Alessandra Casonato, et al.
Published: (2016-01-01)

Pharmacokinetic-Pharmacodynamic Comparison of Recombinant and Plasma-Derived von Willebrand Factor in Patients with von Willebrand Disease Type 3
by: Bauer A, et al.
Published: (2023-06-01)

Structure and Function of Recombinant versus Plasma-Derived von Willebrand Factor and Impact on Multimer Pharmacokinetics in von Willebrand Disease
by: Gritsch H, et al.
Published: (2022-11-01)

Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery.
by: Peyvandi, F, et al.
Published: (2018)

Genetic Variation in the von Willebrand Factor Gene in Swedish von Willebrand Disease Patients
by: Eric Manderstedt, et al.
Published: (2018-01-01)

Role of von Willebrand factor in venous thromboembolic disease
by: Alison Michels, MD, PhD, et al.
Published: (2022-01-01)

The Role of von Willebrand Factor in Microvascular Surgery in Severely Injured Patients
by: René M. Rothweiler, MD, DMD, et al.
Published: (2021-10-01)

Eric Adolf von Willebrand
by: N. A. Makatsariya
Published: (2021-11-01)

The relationship between von willebrand factor gene and von willebrand factor antigen levels in dogs
by: ASLAN Ö, et al.
Published: (2016-07-01)

Improving diagnosis of von Willebrand disease: Reference ranges for von Willebrand factor multimer distribution
by: Inge Vangenechten, et al.
Published: (2020-08-01)

Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies
by: Emmanuel J. Favaloro
Published: (2020-08-01)

Polymorphism in the promoter region of von Willebrand factor gene and von Willebrand disease type 1
by: Daniel Simon, et al.
Published: (2003-12-01)

MISDIAGNOSIS OF ACQUIRED VON WILLEBRAND DISEASE
by: AP Francisco, et al.
Published: (2023-10-01)

The Molecular Genetics of von Willebrand Disease
by: Ergül Berber
Published: (2012-12-01)

Treatment of patients with von Willebrand disease
by: Tuohy E, et al.
Published: (2011-04-01)

Laboratory Diagnosis of von Willebrand's Disease
by: Mansyur Arif
Published: (2009-12-01)

VON WILLEBRAND DISEASE: DIAGNOSIS AND TREATMENT
by: Majda Benedik Dolničar
Published: (2004-12-01)

Management of von willebrand disease in pregnancy
by: Shiny Varghese, et al.
Published: (2017-01-01)

Von Willebrand Factor Multimer Densitometric Analysis: Validation of the Clinical Accuracy and Clinical Implications in Von Willebrand Disease
by: Johan Boender, et al.
Published: (2021-03-01)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
by: Alessandra Casonato, et al.
Published: (2021-08-01)

Total knee arthroplasty in a patient with severe von Willebrand disease (Perioperative treatment of von Willebrand disease)
by: Bralušić Lazar, et al.
Published: (2018-01-01)

Enfermedad de von Willebrand adquirida. Aspectos generales Acquired von Willebrand’s disease. General aspects
by: Alina Díaz Concepción
Published: (2004-04-01)

von Willebrand Factor as a Predictor for Transplant-Associated Thrombotic Microangiopathy
by: Zhenzhen Xu MS, et al.
Published: (2020-02-01)

Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
by: Castaman G, et al.
Published: (2016-06-01)

A Comparative Evaluation of an Automated Functional Assay for Von Willebrand Factor Activity in Type 1 Von Willebrand Disease
by: Lai SW, et al.
Published: (2021-09-01)

The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study
by: Martin Büchsel, et al.
Published: (2023-01-01)

Secretion of von Willebrand Factor and Suppression of ADAMTS-13 Activity by Markedly High Concentration of Ferritin
by: Dalia A. Bashir MD, et al.
Published: (2021-02-01)

Von Willebrand disease : basic and clinical aspects /
by: Federici, Augusto B. 534507
Published: (c201)

The Manifold Cellular Functions of von Willebrand Factor
by: Angelika Mojzisch, et al.
Published: (2021-09-01)

Allopurinol-induced acquired von Willebrand syndrome
by: Juan Eirís, et al.
Published: (2023-10-01)

The role of von Willebrand factor in hemostasis pathology
by: Yu. N. Avtaeva, et al.
Published: (2023-01-01)

Analysis of von Willebrand Disease in the “Heart of Europe”
by: Inge Vangenechten, et al.
Published: (2022-10-01)

Treatment of patients with von Willebrand disease [Erratum]
by: Tuohy E, et al.
Published: (2013-05-01)